{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:15:43Z","timestamp":1795047343360,"version":"4.10.2"},"reference-count":74,"publisher":"Association of Basic Medical Sciences of FBIH","issue":"11","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomol Biomed"],"abstract":"<jats:p>D-galactose has been extensively utilized as a compound to accelerate aging and induce osteoporosis in rodent models. However, variations in dosage, administration routes, and experimental protocols have resulted in inconsistent findings. This scoping review aims to compile preclinical evidence on the use of D-galactose to induce bone loss, with a particular focus on identifying optimal dosing regimens and their specific impacts on skeletal indices. A systematic literature search was conducted in PubMed, Scopus, and Web of Science using predefined terms related to D-galactose-induced osteoporosis in rodents. Eligible studies were selected based on inclusion criteria, concentrating on both in vivo\u00a0and in vitro\u00a0models. A total of 44 studies met these criteria, primarily involving rats and mice. D-galactose was administered via subcutaneous, intraperitoneal, or oral routes, with doses ranging from 10 to 10,000 mg\/kg\/day for durations spanning 20 days to 5 months. The most commonly employed regimen was 200 mg\/kg\/day for 8 weeks. D-galactose consistently induced osteoporotic changes, including reduced bone mineral density, compromised microarchitecture, decreased biomechanical strength, and alterations in bone turnover markers. These skeletal changes were associated with oxidative stress, cellular senescence, and ferroptosis. Susceptibility to these effects was influenced by sex, species, and age, with male rodents generally exhibiting greater sensitivity. In conclusion, D-galactose serves as an effective model for age-related osteoporosis in rodents, primarily mediated by oxidative stress and accelerated cellular senescence. A regimen of 200 mg\/kg\/day administered subcutaneously or intraperitoneally for 8 weeks is commonly used to replicate osteoporotic phenotypes. Greater standardization of protocols is necessary to enhance reproducibility and translational relevance in future studies.<\/jats:p>","DOI":"10.17305\/bb.2026.13914","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:46:07Z","timestamp":1773751567000},"page":"1913-1933","source":"Crossref","is-referenced-by-count":0,"title":["D-galactose-induced osteoporosis in rodents\u2014Model development, skeletal characteristics, and optimal dosing regimens: A scoping review"],"prefix":"10.17305","volume":"26","author":[{"given":"Yuanzhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Lian","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-1552","authenticated-orcid":false,"given":"Kok-Yong","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6922","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"85743","doi-asserted-by":"crossref","unstructured":"Yu F, Xia W. The epidemiology of osteoporosis, associated fragility fractures, and management gap in China. Arch Osteoporos. 2019;14(1):32. https:\/\/doi.org\/10.1007\/s11657-018-0549-y","DOI":"10.1007\/s11657-018-0549-y"},{"key":"85744","doi-asserted-by":"crossref","unstructured":"Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2022;17(1):58. https:\/\/doi.org\/10.1007\/s11657-022-01061-5","DOI":"10.1007\/s11657-022-01115-8"},{"key":"85745","doi-asserted-by":"crossref","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133(1):105\u201317. https:\/\/doi.org\/10.1093\/bmb\/ldaa005","DOI":"10.1093\/bmb\/ldaa005"},{"key":"85746","doi-asserted-by":"crossref","unstructured":"Sfeir JG, Drake MT, Khosla S, Farr JN. Skeletal aging. Mayo Clin Proc. 2022;97(6):1194\u2013208. https:\/\/doi.org\/10.1016\/j.mayocp.2022.03.011","DOI":"10.1016\/j.mayocp.2022.03.011"},{"key":"85747","doi-asserted-by":"crossref","unstructured":"Ding Q, Zhou B, Leung J, Kwok T, Su Y. Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age\u2013period\u2013cohort analysis. Osteoporos Int. 2025. https:\/\/doi.org\/10.1007\/s00198-025-07570-6","DOI":"10.1007\/s00198-025-07570-6"},{"key":"85748","doi-asserted-by":"crossref","unstructured":"Muschitz C, Hummer M, Grillari J, Hlava A, Birner AH, Hemetsberger M, et al. Epidemiology and economic burden of fragility fractures in Austria. Osteoporos Int. 2022;33(3):637\u201347. https:\/\/doi.org\/10.1007\/s00198-021-06152-6","DOI":"10.1007\/s00198-021-06152-6"},{"key":"85749","doi-asserted-by":"crossref","unstructured":"Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","DOI":"10.1007\/s11657-020-0706-y"},{"key":"85750","doi-asserted-by":"crossref","unstructured":"Liang H, Chen S, Shi M, Xu J, Zhao C, Yang B, et al. Global epidemiology and burden of osteoporosis among postmenopausal women: insights from the Global Burden of Disease Study 2021. npj Aging. 2025;11(1):78. https:\/\/doi.org\/10.1038\/s41514-025-00269-2","DOI":"10.1038\/s41514-025-00269-2"},{"key":"85751","doi-asserted-by":"crossref","unstructured":"Aibar-Almaz\u00e1n A, Voltes-Mart\u00ednez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcel\u00e9n-Fraile MDC, L\u00f3pez-Ruiz E. Current status of the diagnosis and management of osteoporosis. Int J Mol Sci. 2022;23(16):9465. https:\/\/doi.org\/10.3390\/ijms23169465","DOI":"10.3390\/ijms23169465"},{"key":"85752","doi-asserted-by":"crossref","unstructured":"Skj\u00f8dt MK, Frost M, Abrahamsen B. Side effects of drugs for osteoporosis and metastatic bone disease. Br J Clin Pharmacol. 2019;85(6):1063\u201371. https:\/\/doi.org\/10.1111\/bcp.13759","DOI":"10.1111\/bcp.13759"},{"key":"85753","doi-asserted-by":"crossref","unstructured":"Qadir A, Liang S, Wu Z, Chen Z, Hu L, Qian A. Senile osteoporosis: the involvement of differentiation and senescence of bone marrow stromal cells. Int J Mol Sci. 2020;21(1):349. https:\/\/doi.org\/10.3390\/ijms21010349","DOI":"10.3390\/ijms21010349"},{"key":"85754","doi-asserted-by":"crossref","unstructured":"Buettmann EG, Goldscheitter GM, Hoppock GA, Friedman MA, Suva LJ, Donahue HJ. Similarities between disuse and age-induced bone loss. J Bone Miner Res. 2022;37(8):1417\u201334. https:\/\/doi.org\/10.1002\/jbmr.4643","DOI":"10.1002\/jbmr.4643"},{"key":"85755","doi-asserted-by":"crossref","unstructured":"Jilka RL. The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci. 2013;68(10):1209\u201317. https:\/\/doi.org\/10.1093\/gerona\/glt046","DOI":"10.1093\/gerona\/glt046"},{"key":"85756","doi-asserted-by":"crossref","unstructured":"Gelles K, Butylina M, Pietschmann P. Animal models for age-related osteoporosis. Gerontology. 2025:1\u201329. https:\/\/doi.org\/10.1159\/000546107","DOI":"10.1159\/000546107"},{"key":"85757","doi-asserted-by":"crossref","unstructured":"Sarygina E, Kliuchnikova A, Tarbeeva S, Ilgisonis E, Ponomarenko E. Model organisms in aging research: evolution of database annotation and ortholog discovery. Genes (Basel). 2025;16(1):8. https:\/\/doi.org\/10.3390\/genes16010008","DOI":"10.3390\/genes16010008"},{"key":"85758","doi-asserted-by":"crossref","unstructured":"Harkema L, Youssef SA, de Bruin A. Pathology of mouse models of accelerated aging. Vet Pathol. 2016;53(2):366\u201389. https:\/\/doi.org\/10.1177\/0300985815625169","DOI":"10.1177\/0300985815625169"},{"key":"85759","doi-asserted-by":"crossref","unstructured":"Guan Q, Zhang Y, Wang ZK, Liu XH, Zou J, Zhang LL. Skeletal phenotypes and molecular mechanisms in aging mice. Zool Res. 2024;45(4):724\u201346. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2023.397","DOI":"10.24272\/j.issn.2095-8137.2023.397"},{"key":"85760","doi-asserted-by":"crossref","unstructured":"Sommer NG, Hahn D, Okutan B, Marek R, Weinberg AM. Animal models in orthopedic research: the proper animal model to answer fundamental questions on bone healing depending on pathology and implant material. In: Tvrd\u00e1 E, Chandra Yenisetti SC, editors. Animal Models in Medicine and Biology. Rijeka: IntechOpen; 2020. https:\/\/doi.org\/10.5772\/intechopen.89137","DOI":"10.5772\/intechopen.89137"},{"key":"85761","doi-asserted-by":"crossref","unstructured":"Wang S, Feng W, Liu J, Wang X, Zhong L, Lv C, et al. Alginate oligosaccharide alleviates senile osteoporosis via the RANKL\u2013RANK pathway in D-galactose-induced C57BL\/6J mice. Chem Biol Drug Des. 2022;99(1):46\u201355. https:\/\/doi.org\/10.1111\/cbdd.13904","DOI":"10.1111\/cbdd.13904"},{"key":"85762","doi-asserted-by":"crossref","unstructured":"Imerb N, Thonusin C, Pratchayasakul W, Chanpaisaeng K, Aeimlapa R, Charoenphandhu N, et al. Hyperbaric oxygen therapy exerts anti-osteoporotic effects in obese and lean D-galactose-induced aged rats. FASEB J. 2023;37(11):e23262. https:\/\/doi.org\/10.1096\/fj.202301197RR","DOI":"10.1096\/fj.202301197RR"},{"key":"85763","doi-asserted-by":"crossref","unstructured":"Imerb N, Thonusin C, Pratchayasakul W, Arunsak B, Nawara W, Ongnok B, et al. D-galactose-induced aging aggravates obesity-induced bone dyshomeostasis. Sci Rep. 2022;12(1):8580. https:\/\/doi.org\/10.1038\/s41598-022-12206-4","DOI":"10.1038\/s41598-022-12206-4"},{"key":"85764","doi-asserted-by":"crossref","unstructured":"Imerb N, Thonusin C, Pratchayasakul W, Arunsak B, Nawara W, Aeimlapa R, et al. Hyperbaric oxygen therapy improves age-induced bone dyshomeostasis in non-obese and obese conditions. Life Sci. 2022;295:120406. https:\/\/doi.org\/10.1016\/j.lfs.2022.120406","DOI":"10.1016\/j.lfs.2022.120406"},{"key":"85765","doi-asserted-by":"crossref","unstructured":"Hung YT, Tikhonova MA, Ding SJ, Kao PF, Lan HH, Liao JM, et al. Effects of chronic treatment with diosgenin on bone loss in a D-galactose-induced aging rat model. Chin J Physiol. 2014;57(3):121\u20137. https:\/\/doi.org\/10.4077\/CJP.2014.BAC199","DOI":"10.4077\/CJP.2014.BAC199"},{"key":"85766","doi-asserted-by":"crossref","unstructured":"Hu H, Yao Y, Liu F, Luo L, Liu J, Wang X, et al. Integrated microbiome and metabolomics revealed the protective effect of baicalin on alveolar bone inflammatory resorption in aging. Phytomedicine. 2024;124:155233. https:\/\/doi.org\/10.1016\/j.phymed.2023.155233","DOI":"10.1016\/j.phymed.2023.155233"},{"key":"85767","doi-asserted-by":"crossref","unstructured":"Martinovic J, Gusevac Stojanovic I, Nesic S, Todorovic A, Bobic K, Stankovic S, et al. Chronic oral D-galactose induces oxidative stress but not overt organ dysfunction in male Wistar rats. Curr Issues Mol Biol. 2025;47(3):161. https:\/\/doi.org\/10.3390\/cimb47030161","DOI":"10.3390\/cimb47030161"},{"key":"85768","doi-asserted-by":"crossref","unstructured":"Cardoso A, Magano S, Marrana F, Andrade JP. D-galactose high-dose administration failed to induce accelerated aging changes in neurogenesis, anxiety, and spatial memory on young male Wistar rats. Rejuvenation Res. 2015;18(6):497\u2013507. https:\/\/doi.org\/10.1089\/rej.2015.1684","DOI":"10.1089\/rej.2015.1684"},{"key":"85769","doi-asserted-by":"crossref","unstructured":"Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616","DOI":"10.1080\/1364557032000119616"},{"key":"85770","doi-asserted-by":"crossref","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850","DOI":"10.7326\/M18-0850"},{"key":"85771","doi-asserted-by":"crossref","unstructured":"Ali MA, Abdulazeez ZM. A histo-physiological study of the effect of resveratrol on osteoporosis induced in rats. South Eastern European Journal of Public Health. 2024:7\u201313. https:\/\/doi.org\/10.70135\/seejph.vi.951","DOI":"10.70135\/seejph.vi.951"},{"key":"85772","doi-asserted-by":"crossref","unstructured":"Baseem T, Albazi W, Mousa RF, Mahmood HB. Inhibition of the RANK\/RANKL\/OPG\/cathepsin K pathway on osteoclast activity by treadmill exercise in osteoporosis induced by D-galactose in male rats. Iraqi J Vet Sci. 2024;38(Suppl I\u2013IV):17\u201326. https:\/\/doi.org\/10.33899\/ijvs.2024.146999.3476","DOI":"10.33899\/ijvs.2024.146999.3476"},{"key":"85773","doi-asserted-by":"crossref","unstructured":"Chen Y, Li YQ, Fang JY, Li P, Li F. Establishment of the concurrent experimental model of osteoporosis combined with Alzheimer's disease in rat and the dual-effects of echinacoside and acteoside from Cistanche tubulosa. J Ethnopharmacol. 2020;257:112834. https:\/\/doi.org\/10.1016\/j.jep.2020.112834","DOI":"10.1016\/j.jep.2020.112834"},{"key":"85774","unstructured":"Dong XW, Zhang J, Zhang X, Zhang Z, Lu J, Gao J, et al. The improvement effect and metabolic mechanism of Echinops sphaerocephalus extract on osteoporosis model rat. China Pharmacy. 2023;34:413\u20138."},{"key":"85775","doi-asserted-by":"crossref","unstructured":"El-Baz FK, Saleh DO, Abdel Jaleel GA, Hussein RA, Hassan A. Haematococcus pluvialis ameliorates bone loss in experimentally induced osteoporosis in rats via the regulation of OPG\/RANKL pathway. Biomed Pharmacother. 2019;116:109017. https:\/\/doi.org\/10.1016\/j.biopha.2019.109017","DOI":"10.1016\/j.biopha.2019.109017"},{"key":"85776","doi-asserted-by":"crossref","unstructured":"He X, Yan C, Zhao S, Zhao Y, Huang R, Li Y. The preventive effects of probiotic Akkermansia muciniphila on D-galactose\/AlCl3-mediated Alzheimer's disease-like rats. Exp Gerontol. 2022;170:111959. https:\/\/doi.org\/10.1016\/j.exger.2022.111959","DOI":"10.1016\/j.exger.2022.111959"},{"key":"85777","doi-asserted-by":"crossref","unstructured":"Hsu WH, Shiao YJ, Chao YM, Huang YJ, Lin YL. T1-11, an adenosine derivative, ameliorates aging-related behavioral physiology and senescence markers in aging mice. Aging (Albany NY). 2020;12(11):10556\u201377. https:\/\/doi.org\/10.18632\/aging.103279","DOI":"10.18632\/aging.103279"},{"key":"85778","doi-asserted-by":"crossref","unstructured":"Inaba M, Terada M, Nishizawa Y, Shioi A, Ishimura E, Otani S, et al. Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism. 1999;48(7):904\u20139. https:\/\/doi.org\/10.1016\/S0026-0495(99)90227-5","DOI":"10.1016\/S0026-0495(99)90227-5"},{"key":"85779","doi-asserted-by":"crossref","unstructured":"Kaushal SK, Parul, Tripathi A, Singh DP, Paul A, Alka K, et al. IL-33 prevents age-related bone loss and memory impairment by suppression of Th17 response: evidence in a D-galactose-induced aging mouse model. JBMR Plus. 2024;8(10):ziae101. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae101","DOI":"10.1093\/jbmrpl\/ziae101"},{"key":"85780","doi-asserted-by":"crossref","unstructured":"Li L, Chen B, Zhu R, Li R, Tian Y, Liu C, et al. Fructus Ligustri Lucidi preserves bone quality through the regulation of gut microbiota diversity, oxidative stress, TMAO and Sirt6 levels in aging mice. Aging (Albany NY). 2019;11(21):9348\u201368. https:\/\/doi.org\/10.18632\/aging.102376","DOI":"10.18632\/aging.102376"},{"key":"85781","doi-asserted-by":"crossref","unstructured":"Li N, Dong X, Ma F, Tian X, Bu R, Li C, et al. Pharmacokinetics study of 16 active ingredients from Tabson-2 decoction in normal and D-galactose-induced osteoporosis rats by liquid chromatography\u2013tandem mass spectrometry. J Sep Sci. 2020;43(18):3702\u201313. https:\/\/doi.org\/10.1002\/jssc.202000355","DOI":"10.1002\/jssc.202000355"},{"key":"85782","doi-asserted-by":"crossref","unstructured":"Li K, Huang K, Lu Q, Geng W, Jiang D, Guo A. TRIM16 mitigates impaired osteogenic differentiation and antioxidant response in D-galactose-induced senescent osteoblasts. Eur J Pharmacol. 2024;979:176849. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176849","DOI":"10.1016\/j.ejphar.2024.176849"},{"key":"85783","doi-asserted-by":"crossref","unstructured":"Li M, Niu Y, Tian L, Zhang T, Zhou S, Wang L, et al. Astragaloside IV alleviates macrophage senescence and D-galactose-induced bone loss in mice through STING\/NF-\u03baB pathway. Int Immunopharmacol. 2024;129:111588. https:\/\/doi.org\/10.1016\/j.intimp.2024.111588","DOI":"10.1016\/j.intimp.2024.111588"},{"key":"85784","unstructured":"Liang MT, Lyu SM, Wang KX, Xu BL, Wu T. Evaluation of D-galactose-induced osteoporosis in male mice by micro-CT and preventive effect of calcitriol. Chinese Pharmacological Bulletin. 2019;35:391\u20135."},{"key":"85785","doi-asserted-by":"crossref","unstructured":"Liu F, Yao Y, Huang Y, Luo L, Wang Q, Chen B, et al. Gut microbiota and metabolic profile changes unveil the deterioration of alveolar bone inflammatory resorption with aging induced by D-galactose. Sci Rep. 2024;14(1):26135. https:\/\/doi.org\/10.1038\/s41598-024-75941-w","DOI":"10.1038\/s41598-024-75941-w"},{"key":"85786","doi-asserted-by":"crossref","unstructured":"Liu H, Huang B, Xue S, U KP, Tsang LL, Zhang X, et al. Functional crosstalk between mTORC1\/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs. Stem Cell Res Ther. 2020;11(1):279. https:\/\/doi.org\/10.1186\/s13287-020-01798-1","DOI":"10.1186\/s13287-020-01798-1"},{"key":"85787","unstructured":"Luo HM, Cui L, Wu T. The different effects of D-galactose on bone histomorphometry in different gender rats. Chinese Pharmacological Bulletin. 2004;20(10):1182\u20135."},{"key":"85788","unstructured":"Lyu SM, Yu Q, Si-Tu YL, Sun JY, Gui U, Wu T. Protective effect of red yeast rice capsule containing coenzyme Q10 on osteoporosis in rats induced by ovariectomy combined with D-galactose. Chinese Pharmacological Bulletin. 2016;32:1253\u20139."},{"key":"85789","doi-asserted-by":"crossref","unstructured":"Mahmoud MAA, Saleh DO, Safar MM, Agha AM, Khattab MM. Chloroquine ameliorates bone loss induced by D-galactose in male rats via inhibition of ERK-associated osteoclastogenesis and antioxidant effect. Toxicol Rep. 2021;8:366\u201375. https:\/\/doi.org\/10.1016\/j.toxrep.2021.02.007","DOI":"10.1016\/j.toxrep.2021.02.007"},{"key":"85790","doi-asserted-by":"crossref","unstructured":"Mahmoud MA, Safar MM, Agha AM, Khattab MM, Saleh DO. Telmisartan: an angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats. Fundam Clin Pharmacol. 2022;36(5):869\u201378. https:\/\/doi.org\/10.1111\/fcp.12779","DOI":"10.1111\/fcp.12779"},{"key":"85791","unstructured":"Pei LP, Hui BD, Dong FH. Influence of canthaxanthin on D-galactose-induced osseous changes of rat. Zhongguo Gu Shang. 2008;21(8):613\u20136."},{"key":"85792","unstructured":"Qin DY, Wu T, Cui L, Wang HL, Liu XQ. The effect of D-galactose on bone metabolism in mice and its mechanism. Chinese Pharmacological Bulletin. 2003;19:1017\u20139."},{"key":"85793","unstructured":"Ruan CL, Bai YJ, Liu YL. Effect of different time aerobic exercises on osseous composition in aging rats. Journal of Clinical Rehabilitative Tissue Engineering Research. 2009;13:5499\u2013504."},{"key":"85794","doi-asserted-by":"crossref","unstructured":"Shen X, Zhang M, Cai H, Leslie WD, Lix LM, Jiang D, et al. Associations of global biomarkers of oxidative stress with osteoporosis, bone microstructure and bone turnover: evidence from human and animal studies. Bone. 2024;183:117077. https:\/\/doi.org\/10.1016\/j.bone.2024.117077","DOI":"10.1016\/j.bone.2024.117077"},{"key":"85795","unstructured":"Si-Tu YL, Ke X, Liu Y, L\u00fc SM, Zhong YC, Cui L, et al. The observation and evaluation of bone histomorphometry in three osteoporosis models of mice. Chinese Pharmacological Bulletin. 2014;30:1281\u20137."},{"key":"85796","doi-asserted-by":"crossref","unstructured":"Su W, Lv C, Huang L, Zheng X, Yang S. Glucosamine delays the progression of osteoporosis in senile mice by promoting osteoblast autophagy. Nutr Metab (Lond). 2022;19(1):75. https:\/\/doi.org\/10.1186\/s12986-022-00688-y","DOI":"10.1186\/s12986-022-00688-y"},{"key":"85797","doi-asserted-by":"crossref","unstructured":"Wang Q, Gao Z, Guo K, Lu J, Wang F, Wu T, et al. Human umbilical cord Wharton jelly cells treatment prevents osteoporosis induced by D-galactose. Int J Clin Pract. 2022;2022:4593443. https:\/\/doi.org\/10.1155\/2022\/4593443","DOI":"10.1155\/2022\/4593443"},{"key":"85798","doi-asserted-by":"crossref","unstructured":"Wu Y, Gao LJ, Fan YS, Chen Y, Li Q. Network pharmacology-based analysis on the action mechanism of oleanolic acid to alleviate osteoporosis. ACS Omega. 2021;6(42):28410\u201320. https:\/\/doi.org\/10.1021\/acsomega.1c04825","DOI":"10.1021\/acsomega.1c04825"},{"key":"85799","doi-asserted-by":"crossref","unstructured":"Wu Y, Hu Y, Zhao Z, Xu L, Chen Y, Liu T, et al. Protective effects of water extract of Fructus Ligustri Lucidi against oxidative stress-related osteoporosis in vivo and in vitro. Vet Sci. 2021;8(9):198. https:\/\/doi.org\/10.3390\/vetsci8090198","DOI":"10.3390\/vetsci8090198"},{"key":"85800","unstructured":"Xiong Y, Zhao F, Liu B, Zhao L. Improving effects of Grifola frondosa polypeptide-calcium chelate on senile osteoporosis in mice. Journal of Chinese Institute of Food Science and Technology. 2022;22:169\u201377."},{"key":"85801","doi-asserted-by":"crossref","unstructured":"Xiong Y, Li JR, Peng PZ, Liu B, Zhao LN. Positive effect of peptide-calcium chelates from Grifola frondosa on a mouse model of senile osteoporosis. J Food Sci. 2024;89(6):3816\u201328. https:\/\/doi.org\/10.1111\/1750-3841.17073","DOI":"10.1111\/1750-3841.17073"},{"key":"85802","doi-asserted-by":"crossref","unstructured":"Xu W, Liu X, He X, Jiang Y, Zhang J, Zhang Q, et al. Bajitianwan attenuates D-galactose-induced memory impairment and bone loss through suppression of oxidative stress in aging rat model. J Ethnopharmacol. 2020;261:112992. https:\/\/doi.org\/10.1016\/j.jep.2020.112992","DOI":"10.1016\/j.jep.2020.112992"},{"key":"85803","doi-asserted-by":"crossref","unstructured":"Xu P, Lin B, Deng X, Huang K, Zhang Y, Wang N. VDR activation attenuates osteoblastic ferroptosis and senescence by stimulating the Nrf2\/GPX4 pathway in age-related osteoporosis. Free Radic Biol Med. 2022;193(Pt 2):720\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.013","DOI":"10.1016\/j.freeradbiomed.2022.11.013"},{"key":"85804","doi-asserted-by":"crossref","unstructured":"Xu S, Xia T, Zhang J, Jiang Y, Wang N, Xin H. Protective effects of bitter acids from Humulus lupulus L. against senile osteoporosis via activating Nrf2\/HO-1\/NQO1 pathway in D-galactose-induced aging mice. J Funct Foods. 2022;94:105099. https:\/\/doi.org\/10.1016\/j.jff.2022.105099","DOI":"10.1016\/j.jff.2022.105099"},{"key":"85805","doi-asserted-by":"crossref","unstructured":"Yu Y, Wu J, Li J, Liu Y, Zheng X, Du M, et al. Cycloastragenol prevents age-related bone loss: evidence in D-galactose-treated and aged rats. Biomed Pharmacother. 2020;128:110304. https:\/\/doi.org\/10.1016\/j.biopha.2020.110304","DOI":"10.1016\/j.biopha.2020.110304"},{"key":"85806","unstructured":"Zhang XL, Wu XN, Chen WS, Chen CL, Xu BL, Zou LY, et al. Effects of ginseng flower bud on bone metabolism in rats induced by D-galactose. Chinese Pharmacological Bulletin. 2017;33:1152\u20138."},{"key":"85807","unstructured":"Li QW, Wang YZ, Guan LC, Gao J, Li W, Qin Z, et al. Effect of different concentrations of Astragali Radix-containing serum on CYP24A1 and CYP27B1 mRNA and protein in osteogenic differentiation of aging bone marrow mesenchymal stem cells. Chinese Journal of Experimental Traditional Medical Formulae. 2020;26:49\u201355."},{"key":"85808","doi-asserted-by":"crossref","unstructured":"Liu LL, Liu ZR, Cao LJ, Wang J, Huang SM, Hu SG, et al. Iron accumulation induced by hepcidin1 knockout accelerates the progression of aging osteoporosis. J Orthop Surg Res. 2024;19(1):59. https:\/\/doi.org\/10.1186\/s13018-024-04535-z","DOI":"10.1186\/s13018-024-04535-z"},{"key":"85809","doi-asserted-by":"crossref","unstructured":"Lin CY, Kang JH. Mechanical properties of compact bone defined by the stress\u2013strain curve measured using uniaxial tensile test: a concise review and practical guide. Materials (Basel). 2021;14(15):4224. https:\/\/doi.org\/10.3390\/ma14154224","DOI":"10.3390\/ma14154224"},{"key":"85810","doi-asserted-by":"crossref","unstructured":"Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073. https:\/\/doi.org\/10.3390\/cells9092073","DOI":"10.3390\/cells9092073"},{"key":"85811","doi-asserted-by":"crossref","unstructured":"Zhu S, Chen W, Masson A, Li YP. Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis. Cell Discov. 2024;10(1):71. https:\/\/doi.org\/10.1038\/s41421-024-00689-6","DOI":"10.1038\/s41421-024-00689-6"},{"key":"85812","doi-asserted-by":"crossref","unstructured":"Bolamperti S, Villa I, Rubinacci A. Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res. 2022;10(1):48. https:\/\/doi.org\/10.1038\/s41413-022-00219-8","DOI":"10.1038\/s41413-022-00219-8"},{"key":"85813","doi-asserted-by":"crossref","unstructured":"Hsu SH, Chen LR, Chen KH. Primary osteoporosis induced by androgen and estrogen deficiency: the molecular and cellular perspective on pathophysiological mechanisms and treatments. Int J Mol Sci. 2024;25(22):12139. https:\/\/doi.org\/10.3390\/ijms252212139","DOI":"10.3390\/ijms252212139"},{"key":"85814","doi-asserted-by":"crossref","unstructured":"Ng M, Hazrati LN. Evidence of sex differences in cellular senescence. Neurobiol Aging. 2022;120:88\u2013104. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.08.014","DOI":"10.1016\/j.neurobiolaging.2022.08.014"},{"key":"85815","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang Z, Jiao W, Wang Y, Wang X, Zhao Y, et al. Ferroptosis and its role in skeletal muscle diseases. Front Mol Biosci. 2022;9:1051866. https:\/\/doi.org\/10.3389\/fmolb.2022.1051866","DOI":"10.3389\/fmolb.2022.1051866"},{"key":"85816","doi-asserted-by":"crossref","unstructured":"Koh NYY, Miszkiewicz JJ, Fac ML, Wee NKY, Sims NA. Preclinical rodent models for human bone disease, including a focus on cortical bone. Endocr Rev. 2024;45(4):493\u2013520. https:\/\/doi.org\/10.1210\/endrev\/bnae004","DOI":"10.1210\/endrev\/bnae004"}],"container-title":["Biomolecules and Biomedicine"],"original-title":[],"link":[{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/13914\/4155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/download\/13914\/4155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:19:34Z","timestamp":1795043974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjbms.org\/ojs\/index.php\/bjbms\/article\/view\/13914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,4]]}},"URL":"https:\/\/doi.org\/10.17305\/bb.2026.13914","relation":{},"ISSN":["2831-090X","2831-0896"],"issn-type":[{"value":"2831-090X","type":"electronic"},{"value":"2831-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}